In the News
Guest Blog Post #12: Protecting the human right to try: Evidence-based deprescription of antipsychotic medication
Hello, deprescribing world. Today we have Dr. Helene Speyer, MD, Ph.D. at Mental Health Center Copenhagen (Denmark), telling us about an ongoing project on deprescribing of antipsychotics. Take it away, Helene! “When can I get off this medication?” Most people taking...
Guest Blog Post #11: Deprescribing experiences from a primary care pharmacist
Welcome to another guest blog post. Today we have Cynthia Leung, pharmacist at the Queen’s Family Health Team (in Kingston, Canada) and the person behind the blog DRUGOPINIONS, sharing her experiences with deprescribing as practicing pharmacist in primary care,...
Nursing Home Residents as a Priority Population for Deprescribing
Welcome to our 10th guest blog post. Today Dr. Joshua Niznik of the University of North Carolina will tell us about his work on overtreatment and deprescribing in nursing home residents in the US. Take it away! Nursing Home Residents are a Priority Population for...
Interview #2: Challenges related to deprescribing and conducting (deprescribing) research among care home residents
Hello, deprescribing world! It has been some time since our first interview blog post, so here is a new one: Today we have Dr. Karen Andersen-Ranberg, Consultant Geriatrician at Odense University Hospital and Professor of Geriatric Medicine at the University of...
Guest Blog Post #9: Deprescribing for healthcare students: What do they need to know?
Hello, depriscribers, welcome to another guest blog post! Today we have Dr. Sion Scott from the University of East Anglia (UK) following up with thoughts on the recent blog post regarding healthcare students’ knowledge about deprescribing. Teaching deprescribing A...